KEGG   DRUG: D08946Help
Entry
D08946                      Drug                                   

Name
Mipomersen sodium (USAN);
Kynamro (TN)
Product
Formula
C230H305N67Na19O122P19S19
Exact mass
7589.7486
Mol weight
7594.8005
Sequence

5'-mG-mC*-mC*-mU*-mC*-dA-dG-dT-dC*-dT-dG-dC*-dT-dT-dC*-mG-mC*-mA-mC*-mC*-3'
2'-O-(2-methoxyethyl) nucleoside (m) and 2'-deoxynucleoside (d)
with  methyl  group  at  position  5 of  C  and  U  (*)
  Type
Nucleotide
Activity
Treatment of hypercholesterolemia
Remark
ATC code: 
Comment
Antisense oligonucleotide
Target
apoB-100 mRNA [HSA:338] [KO:K14462]
Interaction
Genomic biomarker: LDLR [HSA:3949]
Drug interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 C CARDIOVASCULAR SYSTEM
  C10 LIPID MODIFYING AGENTS
   C10A LIPID MODIFYING AGENTS, PLAIN
    C10AX Other lipid modifying agents
     C10AX11 Mipomersen
      D08946  Mipomersen sodium (USAN)
USP drug classification [BR:br08302]
 Cardiovascular Agents
  Dyslipidemics, Other
   Mipomersen
    D08946  Mipomersen sodium (USAN)
Target-based classification of drugs [BR:br08310]
 Others
  Heparin binding proteins
   apoB-100 mRNA
    Mipomersen
     D08946  Mipomersen sodium (USAN)
Hypolipidemic agents [br08365.html]
 D08946
New drug approvals in the USA [br08319.html]
 New Molecular Entity and New Therapeutic Biological Product Approvals
  D08946
Pharmacogenomic biomarkers in FDA drug labels [br08341.html]
 Polymorphisms and germline mutations
  D08946
BRITE hierarchy
Other DBs
CAS: 
629167-92-6
PubChem: 
LinkDB All DBs

» Japanese version   » Back

DBGET integrated database retrieval system